Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 1
2002 6
2003 7
2004 17
2005 23
2006 25
2007 13
2008 5
2009 4
2010 14
2011 18
2012 15
2013 18
2014 15
2015 17
2016 14
2017 35
2018 35
2019 37
2020 46
2021 45
2022 53
2023 48
2024 38
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

455 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Reply.
de Parisot A, Jamilloux Y, Kodjikian L, Errera MH, Sedira N, Heron E, Pérard L, Cornut PL, Schneider C, Rivière S, Ollé P, Pugnet G, Cathébras P, Manoli P, Bodaghi B, Saadoun D, Baillif S, Tieulie N, Andre M, Chiambaretta F, Bonin N, Bielefeld P, Bron A, Mouriaux F, Bienvenu B, Vicente S, Bin S, Broussolle C, Decullier E, Sève P. de Parisot A, et al. Among authors: kodjikian l. Am J Ophthalmol. 2017 Jul;179:208-209. doi: 10.1016/j.ajo.2017.04.023. Epub 2017 May 17. Am J Ophthalmol. 2017. PMID: 28528083 No abstract available.
Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee.
Sève P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, Bielefeld P, Sène D, Kaplanski G, Monnet D, Brézin A, Weber M, Saadoun D, Chiquet C, Kodjikian L. Sève P, et al. Among authors: kodjikian l. Autoimmun Rev. 2017 Dec;16(12):1254-1264. doi: 10.1016/j.autrev.2017.10.010. Epub 2017 Oct 14. Autoimmun Rev. 2017. PMID: 29037906 Review.
[Ocular toxoplasmosis].
Sauer A, Schaeffer M, Serrar Y, Kodjikian L. Sauer A, et al. Among authors: kodjikian l. J Fr Ophtalmol. 2024 Dec;47(10):104334. doi: 10.1016/j.jfo.2024.104334. Epub 2024 Oct 28. J Fr Ophtalmol. 2024. PMID: 39490112 Free article. Review. French.
Ocular Sarcoidosis.
Sève P, Jamilloux Y, Tilikete C, Gerfaud-Valentin M, Kodjikian L, El Jammal T. Sève P, et al. Among authors: kodjikian l. Semin Respir Crit Care Med. 2020 Oct;41(5):673-688. doi: 10.1055/s-0040-1710536. Epub 2020 Aug 10. Semin Respir Crit Care Med. 2020. PMID: 32777852 Review.
Sarcoidosis and uveitis.
Jamilloux Y, Kodjikian L, Broussolle C, Sève P. Jamilloux Y, et al. Among authors: kodjikian l. Autoimmun Rev. 2014 Aug;13(8):840-9. doi: 10.1016/j.autrev.2014.04.001. Epub 2014 Apr 3. Autoimmun Rev. 2014. PMID: 24704868 Review.
Sarcoidosis-Related Uveitis: A Review.
Giorgiutti S, Jacquot R, El Jammal T, Bert A, Jamilloux Y, Kodjikian L, Sève P. Giorgiutti S, et al. Among authors: kodjikian l. J Clin Med. 2023 Apr 29;12(9):3194. doi: 10.3390/jcm12093194. J Clin Med. 2023. PMID: 37176633 Free PMC article. Review.
455 results